These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 4288023

  • 21. Studies of live attenuated Japanese encephalitis vaccine in swine.
    Kodama K, Sasaki N, Inoue YK.
    J Immunol; 1968 Jan; 100(1):194-200. PubMed ID: 4295062
    [No Abstract] [Full Text] [Related]

  • 22. Studies on the neutralization of Japanese encephalitis virus. II. Variations in reaction properties of virus to antibody during replication in PS cell cultures.
    Ozaki Y, Kumagai K.
    J Immunol; 1969 Oct; 103(4):850-6. PubMed ID: 4310740
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hemagglutin of Japanese encephalitis virus produced in embryonic swine kidney cell cultures.
    Sugimori T, Morimoto T, Miura Y, Sazawa H.
    Natl Inst Anim Health Q (Tokyo); 1969 Oct; 9(2):55-64. PubMed ID: 4310355
    [No Abstract] [Full Text] [Related]

  • 26. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR, Elliston NG, Miyat JA, Grueter HP, Gillespie JR, Rathmacher RP.
    Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract] [Full Text] [Related]

  • 27. Reaction with mannan of a live Japanese encephalitis virus vaccine.
    Nozima T, Yasui K.
    Acta Virol; 1971 Mar; 15(2):174. PubMed ID: 4396417
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.
    J Infect Dis; 2003 Oct 15; 188(8):1213-30. PubMed ID: 14551893
    [Abstract] [Full Text] [Related]

  • 31. Studies on Japanese B encephalitis virus vaccines from tissue culture. IX. Human response to a hamster-kidney tissue-culture inactivated vaccine.
    Darwish MA, Hammon WM, Sather GE.
    Am J Trop Med Hyg; 1967 May 15; 16(3):364-70. PubMed ID: 4290334
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP.
    Virology; 1999 May 10; 257(2):363-72. PubMed ID: 10329547
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Tamiami (TAM) strain. W-10777.
    Am J Trop Med Hyg; 1970 Nov 10; 19(6):Suppl:1157-8. PubMed ID: 4395318
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.